Why Control Bionics' (ASX:CBL) NeuroNode technology is a lifeline for ALS patients
Imported
Why Control Bionics’ (ASX:CBL) NeuroNode technology is a lifeline for ALS patients
Be the First to Comment
Read
Home
Sponsored
Sponsored
Why Control Bionics’ (ASX:CBL) NeuroNode technology is a lifeline for ALS patients
June 23, 2022 11:08 AM AEST
Be the First to Comment
NEW
Manisha
Author
Manisha – Senior Financial Journalist
305 Posts
Manisha is a Senior Financial Journalist at Kalkine Media, covering the Australian market along with world news. She has tons of experience in content development in the media industry. Her deliverables reflect the strong command she has over the lan…
Shwetambri Chauhan
Reviewer
Shwetambri Chauhan – Sr. Research Editor
0 Posts
Shwetambri Chauhan is a Sr. Research Editor at Kalkine Media. She comes with an experience of 11 years in secondary research and quality check. Besides, she has rich experience of working across different sectors and markets. Her professional experie…
Follow
MOST READ
Stock Market
ASX 200 to rise; Wall Street settles lower; oil prices slip
Cryptocurrency
Why did Muse (MUSE) crypto volume soar over 1000%?
Cryptocurrency
Why is Meta Ruffy (MR) rising, defying crypto market dip?
Image source: Company announcement
Highlights
Control Bionics has been making life-changing connections for people with movement and speech disabilities.
The company’s world-class patented NeuroNode technology [...]